LexaGene Holdings Inc. (LXXGF) Comparison with companies in other sectors?

LexaGene Holdings Inc. has a share price of 140.64M. You can analyze LexaGene Holdings Inc. (LXXGF) competitors across different market sectors through stock heatmaps.

What are LXXGF's NET and operating margins?

LexaGene Holdings Inc. (LXXGF) operating margin is around -141.25, and net profit margin is approximately -140.77 as of the latest reports.

In what way does LXXGF's earnings per share (EPS) trend reflect its financial momentum?

LexaGene Holdings Inc. (LXXGF) EPS is -0.10 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for LexaGene Holdings Inc. is -0.85, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for LexaGene Holdings Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for LexaGene Holdings Inc. like P/E which is -0.91, P/B which is 1.52, and PEG which is -0.01. Compare them with sector averages to evaluate if the stock is priced fairly.

LexaGene Holdings Inc.

LXXGF•PNK

Healthcare

Medical - Devices

$0.08

$0.00(0.00%)

LexaGene Holdings Inc. (LXXGF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.10

P/E Ratio

-0.85

ROE

-1.23%

Net Margin

-140.77%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$11.34M

Shares OutstandingTotal number of shares issued

$140.64M

Book Value/ShareNet worth per share

$0.05

Revenue/ShareAnnual revenue per share

$0.001

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.095

Net MarginNet income as percentage of revenue

-14076.87%

Operating MarginOperating income as percentage of revenue

-14125.14%

ROEReturn on shareholders' equity

-122.83%

ROAReturn on total assets

-129.32%

ROCEReturn on capital employed

-146.21%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.08

Cash/ShareCash and equivalents per share

$0.04

FCF YieldFree cash flow as percentage of market cap

-85.25%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for LXXGFFinancial Ratios Analysis details for LXXGF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for LXXGFSector Benchmarking details for LXXGF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for LexaGene Holdings Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of LexaGene Holdings Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account LexaGene Holdings Inc.'s unique business strengths and challenges.

Key Financial Metrics for LexaGene Holdings Inc.

For LexaGene Holdings Inc., essential financial indicators include EPS -0.10, PE -0.85, and ROE -1.23. These key ratios reveal insights into LexaGene Holdings Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare LexaGene Holdings Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of LexaGene Holdings Inc.

Metrics like Net Margin -14076.87% and ROA -129.32% shed light on how well LexaGene Holdings Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether LexaGene Holdings Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of LexaGene Holdings Inc.

Using ratios such as P/B Ratio 1.52 and PEG Ratio -0.01, investors can assess whether LexaGene Holdings Inc. is appropriately valued based on its financials and growth potential. These figures, combined with LexaGene Holdings Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for LexaGene Holdings Inc.

Financial health indicators, such as Debt/Equity Ratio 0.20 and Cash Flow $-0.08, provide a snapshot of LexaGene Holdings Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like LexaGene Holdings Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for LexaGene Holdings Inc.

Investing in LexaGene Holdings Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at LexaGene Holdings Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;